192 related articles for article (PubMed ID: 37082775)
21. Skin adnexal carcinoma with BRD3-NUTM2B fusion.
Rubio Gonzalez B; Ortiz MV; Ross DS; Busam KJ
J Cutan Pathol; 2021 Dec; 48(12):1508-1513. PubMed ID: 34296453
[TBL] [Abstract][Full Text] [Related]
22. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
[TBL] [Abstract][Full Text] [Related]
23. Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review.
Wangsiricharoen S; Wakely PE; Prieto VG; Yu W
Histopathology; 2023 Nov; 83(5):712-721. PubMed ID: 37442637
[TBL] [Abstract][Full Text] [Related]
24. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
25. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract][Full Text] [Related]
27. NUT carcinoma of the lung.
Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
[TBL] [Abstract][Full Text] [Related]
28. NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case.
Agaimy A; Tögel L; Stoehr R; Meidenbauer N; Semrau S; Hartmann A; Mantsopoulos K
Virchows Arch; 2021 Dec; 479(6):1095-1099. PubMed ID: 33891143
[TBL] [Abstract][Full Text] [Related]
29. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
31. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
Chen M; Li S; Jiang L
Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
[TBL] [Abstract][Full Text] [Related]
33. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
McEvoy CR; Holliday H; Thio N; Mitchell C; Choong DY; Yellapu B; Leong HS; Xu H; Lade S; Browning J; Takano EA; Byrne DJ; Gill AJ; Duong CP; Li J; Fellowes AP; Fox SB; Swarbrick A; Prall OWJ
Lab Invest; 2021 Jan; 101(1):26-37. PubMed ID: 32873880
[TBL] [Abstract][Full Text] [Related]
34. NUT Carcinoma of the Submandibular Gland: A Case at This Uncommon Site with Review of the Literature.
Moreno V; French CA; Guo T; Zhu H; Zhang S; Duncan D; Karni RJ; Blanco AI; Jafri SH; Saluja K
Head Neck Pathol; 2022 Sep; 16(3):881-892. PubMed ID: 34905155
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic Features of CIC-NUTM1 Sarcomas, a New Molecular Variant of the Family of CIC-Fused Sarcomas.
Le Loarer F; Pissaloux D; Watson S; Godfraind C; Galmiche-Rolland L; Silva K; Mayeur L; Italiano A; Michot A; Pierron G; Vasiljevic A; Ranchère-Vince D; Coindre JM; Tirode F
Am J Surg Pathol; 2019 Feb; 43(2):268-276. PubMed ID: 30407212
[TBL] [Abstract][Full Text] [Related]
36. Fusion-positive skin/adnexal carcinomas.
Agaimy A
Genes Chromosomes Cancer; 2022 May; 61(5):274-284. PubMed ID: 35167714
[TBL] [Abstract][Full Text] [Related]
37. Case report of a pan-cytokeratin negative NUT midline carcinoma of pulmonary origin, a BRD3-NUT variant: Challenges in cytomorphologic presentation.
Hwang J; Marinelli L; Chormanski D; Rose H; Williams G; Adams T; Van Dellen M
Diagn Cytopathol; 2023 Jul; 51(7):E209-E213. PubMed ID: 37021735
[TBL] [Abstract][Full Text] [Related]
38. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
39. CIC-NUTM1 Sarcomas Affecting the Spine.
Yang S; Liu L; Yan Y; Jiang L; Han S; Shen D; Zhang B
Arch Pathol Lab Med; 2022 Jun; 146(6):735-741. PubMed ID: 34525172
[TBL] [Abstract][Full Text] [Related]
40. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]